By HotStockRockets | Thursday 24 March 2016
Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Shares in Optibiotix (OPTI) slipped back to 66.5p - albeit in thin volumes - two days ago as it announced news which was really not very exciting at all. The news we want we now expect very shortly after Easter. The shares are now 70p. Hang on for what comes next!
So what did Optibiotix say? It has signed a second deal with the IQOG (Instituto de Química Orgánica General) of the Spanish National Research Council (Consejo Superior de Investigaciones Científicas, CSIC) in Madrid extending OptiBiotix development programmes creating sweet healthy oligosaccharides (carbohydrates that consists of a small number of sugars).
So why is this different to deal 1? Optibiotix clarifies:
The first research programme which started in September 2015, is designed to create sweet low calorie sugars using different bacterial strains.
This second program incorporates natural sweeteners into existing or new oligosaccharide chains with the potential to create sweet products with functional health benefits.
What the market wants is a deal stating explicitly that its alternatives to sugar will generate cash. It is that simple. We believe such deals with hard numbers included are very imminent indeed and that this will see the shares jump sharply. So the stance is buy. It is that simple.
Never miss a story.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Search ShareProphets |
Stock market news |
Recent Comments |